Search

Your search keyword '"CATALDO V"' showing total 7 results
Start Over Author "CATALDO V" Language italian
7 results on '"CATALDO V"'

1. Radio-chemioterapia concomitante con regimi a base di antracicline nel trattamento adiuvante del carcinoma mammario: Esperienza di un singolo centro

Author

Livi, L., Meattini, I, Scotti, V., Saieva, C., Simontacchi, G., Marrazzo, L., Franzese, C., Cassani, S., Paiar, Fabiola, Di Cataldo, V., Nori, J., Jose Sanchez, L., Bianchi, S., Cataliotti, L., and Biti, G.

Subjects
Adult, Breast Neoplasms, Risk Assessment, Disease-Free Survival, Risk Factors, Nuclear Medicine and Imaging, Antineoplastic Combined Chemotherapy Protocols, Humans, Chemotherapy, Anthracyclines, Cyclophosphamide, Early Detection of Cancer, Adjuvant, Epirubicin, Retrospective Studies, Concomitant chemoradiotherapy, Radiotherapy, Medicine (all), Early breast cancer, Adjuvant radiotherapy, Cardiac toxicity, Doxorubicin, Feasibility Studies, Female, Fluorouracil, Follow-Up Studies, Methotrexate, Middle Aged, Treatment Outcome, Chemotherapy, Adjuvant, Radiotherapy, Adjuvant, Radiology, Nuclear Medicine and Imaging, Radiology
Published
2011

4. Il diritto applicabile dal Tribunale unificato: il coordinamento tra fonti e i rapporti tra accordo TUB e regolamento (UE) n. 1257/2012

Author

HONORATI, COSTANZA, Baratta, R, Bosshard, N, De Miguel Asensio, P, Di Cataldo, V, Guglielmetti, G, Honorati, C, Modiano, M, Pocar, F., Ricolfi, M, Sandrini, L, Scuffi, M, and Tavassi, M

Subjects
IUS/14 - DIRITTO DELL'UNIONE EUROPEA, European Patent with Unitary Effect, European Patent, C, brevetto ad effetto unitario, IUS/13 - DIRITTO INTERNAZIONALE, Tribunale unificato, brevetto europeo
Abstract

Uno dei punti di maggiore complessità del futuro quadro di tutela berevettuale è costituito dal diritto applicabile dal Tribunale unificato. L'art. 24 dell'accordo TUB indica una pluralità di fonti (diritto UE, diritto convenzionale, diritto nazionale) che devono essere coordinati tra loro. Il contributo in oggetto mira a esaminerne il funzionamento, soffermandosi in particolare sul meccanismo di cui all'art. 7 TUB che, nel disporre il rinvio (materiale) al diritto nazionale, giunge per tale via a rendere applicabile le norme poste dallo stesso TUB. Attenzione è dedicata anche all'ambito di applicazione lasciato alle diverse fonti nei casi di contraffazione e ai rapporti tra profili di giurisdizione e di legge applicabile. One of the crucial issues of the future patent system is the law applicable to patent protection as applied by the upcoming Unfied Patent Court. Article 24 UPCA prescribes application of EU law, treaty law (included but not limited to UPCA and EPA) and national law. All these rules need to be coordinated one with each other. The present study analyzes how such coordination will actually work in regard of different issues. It focus in particular on Article 7 UPCA mechanism as such rule, while prescribing a (material) referrral to national law, aims to make applicable the conventional rules set in the UPCA. Special consideration is also given to the scope of application of the different rules in regards of patent infringement and to the difficult relation between rules on jurisdiction and rules on applicable law.

Published
2014

6. Concomitant adjuvant chemo-radiation therapy with anthracycline-based regimens in breast cancer: a single centre experience.

Author

Livi L, Meattini I, Scotti V, Saieva C, Simontacchi G, Marrazzo L, Franzese C, Cassani S, Paiar F, Di Cataldo V, Nori J, Jose Sanchez L, Bianchi S, Cataliotti L, and Biti G

Subjects
Adult, Antineoplastic Combined Chemotherapy Protocols administration & dosage, Antineoplastic Combined Chemotherapy Protocols adverse effects, Breast Neoplasms diagnosis, Breast Neoplasms surgery, Cyclophosphamide administration & dosage, Disease-Free Survival, Doxorubicin administration & dosage, Early Detection of Cancer, Epirubicin administration & dosage, Feasibility Studies, Female, Fluorouracil administration & dosage, Follow-Up Studies, Humans, Methotrexate administration & dosage, Middle Aged, Retrospective Studies, Risk Assessment, Risk Factors, Treatment Outcome, Anthracyclines administration & dosage, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Breast Neoplasms drug therapy, Breast Neoplasms radiotherapy, Chemotherapy, Adjuvant, Radiotherapy, Adjuvant
Abstract

Purpose: This study was done to evaluate the toxicity related to concurrent radiotherapy and anthracycline (AC)-based chemotherapy in the adjuvant treatment of early breast cancer and to investigate the impact of treatment interruptions and the feasibility of this uncommon therapeutic approach., Materials and Methods: From September 2002 to December 2007, 60 patients were treated at our Centre. The mean age at presentation was 48.5 (range 38-64) years. All patients underwent conservative surgery, and radiotherapy to the entire breast (mean dose 50 Gy; range 46-52 Gy). AC-based regimens consisted of four cycles of AC (doxorubicin plus cyclophosphamide) or four cycles of epirubicin (EPI) followed by four courses of cyclophosphamide, methotrexate and 5-fluorouracil (CMF)., Results: Concomitant treatment caused acute skin G3 toxicity in 8.9% of patients and one case of G4 toxicity (1.7%). Concerning cardiac assessment, six of the 56 evaluable patients (10.7%) developed an asymptomatic decline of left ventricular ejection fraction >10% and <20% of the baseline value. Radiotherapy was temporarily stopped in 21.3% and chemotherapy in 57.1% of patients., Conclusions: In our experience, concomitant chemotherapy did not emerge as a significant factor in radiotherapy interruption. Moreover, no severe cardiac events were recorded.

Published
2011
Full Text
View/download PDF

7. [Lipoprotein(a) and atheromatous disease of epiaortic arterial trunks in the very old].

Author

Spada RS, Ferri R, Mangiafico RA, Roccasalva G, Toscano G, Di Cataldo V, and Santonocito M

Subjects
Age Factors, Aged, Arterial Occlusive Diseases blood, Arteriosclerosis blood, Cerebrovascular Disorders etiology, Enzyme-Linked Immunosorbent Assay, Female, Humans, Lipids blood, Male, Risk Factors, Aged, 80 and over, Arterial Occlusive Diseases epidemiology, Arteriosclerosis epidemiology, Lipoprotein(a) blood
Published
1998

Catalog

Books, media, physical & digital resources
See catalog results